214 related articles for article (PubMed ID: 21596086)
1. Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection.
Barnoy S; Baqar S; Kaminski RW; Collins T; Nemelka K; Hale TL; Ranallo RT; Venkatesan MM
Vaccine; 2011 Aug; 29(37):6371-8. PubMed ID: 21596086
[TBL] [Abstract][Full Text] [Related]
2. Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity.
Barnoy S; Jeong KI; Helm RF; Suvarnapunya AE; Ranallo RT; Tzipori S; Venkatesan MM
Vaccine; 2010 Feb; 28(6):1642-54. PubMed ID: 19932216
[TBL] [Abstract][Full Text] [Related]
3. Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers.
Orr N; Katz DE; Atsmon J; Radu P; Yavzori M; Halperin T; Sela T; Kayouf R; Klein Z; Ambar R; Cohen D; Wolf MK; Venkatesan MM; Hale TL
Infect Immun; 2005 Dec; 73(12):8027-32. PubMed ID: 16299296
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
[TBL] [Abstract][Full Text] [Related]
5. Safety and colonization of two novel VirG(IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta).
Collins TA; Barnoy S; Baqar S; Ranallo RT; Nemelka KW; Venkatesan MM
Comp Med; 2008 Feb; 58(1):88-94. PubMed ID: 19793462
[TBL] [Abstract][Full Text] [Related]
6. A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei.
Frenck RW; Baqar S; Alexander W; Dickey M; McNeal M; El-Khorazaty J; Baughman H; Hoeper A; Barnoy S; Suvarnapunya AE; Kaminski RW; Venkatesan MM
Vaccine; 2018 Aug; 36(32 Pt B):4880-4889. PubMed ID: 30037478
[TBL] [Abstract][Full Text] [Related]
7. Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates.
Ranallo RT; Fonseka S; Boren TL; Bedford LA; Kaminski RW; Thakkar S; Venkatesan MM
Vaccine; 2012 Jul; 30(34):5159-71. PubMed ID: 22658966
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of live Shigella vaccine candidates in rhesus monkeys show no evidence of competition for colonization and immunogenicity between different serotypes.
Ranallo RT; Kaminski R; Baqar S; Dutta M; Lugo-Roman LA; Boren T; Barnoy S; Venkatesan MM
Vaccine; 2014 Mar; 32(15):1754-60. PubMed ID: 24522159
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
Barry EM; Wang J; Wu T; Davis T; Levine MM
Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
[TBL] [Abstract][Full Text] [Related]
10. A phase I trial of WRSS1, a
Raqib R; Sarker P; Zaman K; Alam NH; Wierzba TF; Maier N; Talukder K; Baqui AH; Suvarnapunya AE; Qadri F; Walker RI; Fix A; Venkatesan MM
Hum Vaccin Immunother; 2019; 15(6):1326-1337. PubMed ID: 30794051
[No Abstract] [Full Text] [Related]
11. Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactions.
Bedford L; Fonseka S; Boren T; Ranallo RT; Suvarnapunya AE; Lee JE; Barnoy S; Venkatesan MM
Gut Microbes; 2011; 2(4):244-51. PubMed ID: 21983066
[No Abstract] [Full Text] [Related]
12. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.
McKenzie R; Walker RI; Nabors GS; Van De Verg LL; Carpenter C; Gomes G; Forbes E; Tian JH; Yang HH; Pace JL; Jackson WJ; Bourgeois AL
Vaccine; 2006 May; 24(18):3735-45. PubMed ID: 16095766
[TBL] [Abstract][Full Text] [Related]
13. Oral immunization with
Shrivastava S; Agnememel AB; Ndungo E; Islam D; Liang Y; Frenck RW; Pasetti MF
mSphere; 2024 Jan; 9(1):e0041923. PubMed ID: 38132716
[No Abstract] [Full Text] [Related]
14. Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine.
Venkatesan MM; Hartman AB; Newland JW; Ivanova VS; Hale TL; McDonough M; Butterton J
Infect Immun; 2002 Jun; 70(6):2950-8. PubMed ID: 12010984
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of virulent and live Shigella sonnei vaccine candidates in a gnotobiotic piglet model.
Jeong KI; Venkatesan MM; Barnoy S; Tzipori S
Vaccine; 2013 Aug; 31(37):4039-46. PubMed ID: 23684833
[TBL] [Abstract][Full Text] [Related]
16. Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults.
Pitisuttithum P; Islam D; Chamnanchanunt S; Ruamsap N; Khantapura P; Kaewkungwal J; Kittitrakul C; Luvira V; Dhitavat J; Venkatesan MM; Mason CJ; Bodhidatta L
Clin Vaccine Immunol; 2016 Jul; 23(7):564-75. PubMed ID: 27146000
[TBL] [Abstract][Full Text] [Related]
17. Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.
Venkatesan MM; Ballou C; Barnoy S; McNeal M; El-Khorazaty J; Frenck R; Baqar S
PLoS One; 2021; 16(11):e0259361. PubMed ID: 34793505
[TBL] [Abstract][Full Text] [Related]
18. Fusion of HPV L1 into Shigella surface IcsA: a new approach in developing live attenuated Shigella-HPV vaccine.
Xu D; Wang D; Yang X; Cao M; Yu J; Wang Y
Antiviral Res; 2014 Feb; 102():61-9. PubMed ID: 24333518
[TBL] [Abstract][Full Text] [Related]
19. Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults.
Kotloff KL; Taylor DN; Sztein MB; Wasserman SS; Losonsky GA; Nataro JP; Venkatesan M; Hartman A; Picking WD; Katz DE; Campbell JD; Levine MM; Hale TL
Infect Immun; 2002 Apr; 70(4):2016-21. PubMed ID: 11895966
[TBL] [Abstract][Full Text] [Related]
20. Functional Antibodies and Innate Immune Responses to WRSS1, a Live Oral Shigella sonnei Vaccine Candidate, in Bangladeshi Adults and Children.
Sarker P; Mily A; Ara A; Haque F; Maier N; Wierzba TF; Walker RI; Venkatesan MM; Raqib R
J Infect Dis; 2021 Dec; 224(12 Suppl 2):S829-S839. PubMed ID: 34374425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
